US Stock MarketDetailed Quotes

RVMDW REVOLUTION MEDICINES INC C/WTS (TO PUR COM)

Watchlist
  • 0.080
  • 0.0000.00%
Trading Sep 3 14:18 ET
0Market Cap0.00P/E (TTM)

REVOLUTION MEDICINES INC C/WTS (TO PUR COM) Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
-67.27%11.58M
-95.16%742K
0
-58.05%3.82M
-7.44%7.01M
20.38%35.38M
62.05%15.33M
204.81%3.36M
Operating revenue
--0
--0
-67.27%11.58M
-95.16%742K
--0
-58.05%3.82M
-7.44%7.01M
20.38%35.38M
62.05%15.33M
204.81%3.36M
Cost of revenue
Gross profit
Operating expense
39.09%156.64M
71.42%140.86M
69.84%498.77M
134.60%180.73M
54.27%123.25M
58.16%112.62M
25.40%82.17M
35.08%293.66M
23.51%77.04M
47.22%79.89M
Selling and administrative expenses
48.30%21.71M
72.70%22.84M
86.32%75.62M
195.55%32.24M
48.68%15.51M
43.47%14.64M
46.33%13.22M
33.29%40.59M
25.52%10.91M
33.92%10.43M
-General and administrative expense
48.30%21.71M
72.70%22.84M
86.32%75.62M
195.55%32.24M
48.68%15.51M
43.47%14.64M
46.33%13.22M
33.29%40.59M
25.52%10.91M
33.92%10.43M
Research and development costs
37.71%134.93M
71.18%118.02M
67.20%423.14M
124.54%148.48M
55.11%107.74M
60.62%97.98M
22.05%68.95M
35.37%253.07M
23.19%66.13M
49.45%69.46M
Operating profit
-43.98%-156.64M
-87.42%-140.86M
-88.63%-487.19M
-191.67%-179.98M
-61.04%-123.25M
-75.23%-108.8M
-29.70%-75.16M
-37.38%-258.28M
-16.62%-61.71M
-43.96%-76.53M
Net non-operating interest income expense
104.66%21.49M
236.59%23.76M
415.39%47.18M
267.82%18.67M
276.57%10.95M
1,110.96%10.5M
2,237.42%7.06M
898.26%9.15M
2,042.19%5.08M
1,203.59%2.91M
Non-operating interest income
104.66%21.49M
236.59%23.76M
418.70%47.48M
273.78%18.98M
276.57%10.95M
1,110.96%10.5M
2,237.42%7.06M
885.36%9.15M
2,042.19%5.08M
1,203.59%2.91M
Non-operating interest expense
----
----
--303K
----
----
----
----
--0
----
----
Other net income (expense)
1.92M
1.1M
115K
Gain on sale of security
--1.91M
--3.91M
----
----
----
----
----
----
----
----
Other non- operating income (expenses)
--16K
---2.81M
--115K
----
----
----
----
----
----
----
Income before tax
-35.54%-133.23M
-70.35%-116M
-76.57%-439.89M
-184.64%-161.19M
-52.53%-112.3M
-60.56%-98.3M
-18.13%-68.1M
-33.16%-249.13M
-7.51%-56.63M
-39.07%-73.63M
Income tax
0
0
-739.05%-3.52M
378.86%343K
-1,202.02%-3.87M
0
0
-420K
-123K
-297K
Net income
-35.54%-133.23M
-70.35%-116M
-75.46%-436.37M
-185.87%-161.54M
-47.87%-108.43M
-60.56%-98.3M
-18.13%-68.1M
-32.93%-248.71M
-7.27%-56.51M
-38.51%-73.33M
Net income continuous Operations
-35.54%-133.23M
-70.35%-116M
-75.46%-436.37M
-185.87%-161.54M
-47.87%-108.43M
-60.56%-98.3M
-18.13%-68.1M
-32.93%-248.71M
-7.27%-56.51M
-38.51%-73.33M
Minority interest income
Net income attributable to the parent company
-35.54%-133.23M
-70.35%-116M
-75.46%-436.37M
-185.87%-161.54M
-47.87%-108.43M
-60.56%-98.3M
-18.13%-68.1M
-32.93%-248.71M
-7.27%-56.51M
-38.51%-73.33M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-35.54%-133.23M
-70.35%-116M
-75.46%-436.37M
-185.87%-161.54M
-47.87%-108.43M
-60.56%-98.3M
-18.13%-68.1M
-32.93%-248.71M
-7.27%-56.51M
-38.51%-73.33M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 00-67.27%11.58M-95.16%742K0-58.05%3.82M-7.44%7.01M20.38%35.38M62.05%15.33M204.81%3.36M
Operating revenue --0--0-67.27%11.58M-95.16%742K--0-58.05%3.82M-7.44%7.01M20.38%35.38M62.05%15.33M204.81%3.36M
Cost of revenue
Gross profit
Operating expense 39.09%156.64M71.42%140.86M69.84%498.77M134.60%180.73M54.27%123.25M58.16%112.62M25.40%82.17M35.08%293.66M23.51%77.04M47.22%79.89M
Selling and administrative expenses 48.30%21.71M72.70%22.84M86.32%75.62M195.55%32.24M48.68%15.51M43.47%14.64M46.33%13.22M33.29%40.59M25.52%10.91M33.92%10.43M
-General and administrative expense 48.30%21.71M72.70%22.84M86.32%75.62M195.55%32.24M48.68%15.51M43.47%14.64M46.33%13.22M33.29%40.59M25.52%10.91M33.92%10.43M
Research and development costs 37.71%134.93M71.18%118.02M67.20%423.14M124.54%148.48M55.11%107.74M60.62%97.98M22.05%68.95M35.37%253.07M23.19%66.13M49.45%69.46M
Operating profit -43.98%-156.64M-87.42%-140.86M-88.63%-487.19M-191.67%-179.98M-61.04%-123.25M-75.23%-108.8M-29.70%-75.16M-37.38%-258.28M-16.62%-61.71M-43.96%-76.53M
Net non-operating interest income expense 104.66%21.49M236.59%23.76M415.39%47.18M267.82%18.67M276.57%10.95M1,110.96%10.5M2,237.42%7.06M898.26%9.15M2,042.19%5.08M1,203.59%2.91M
Non-operating interest income 104.66%21.49M236.59%23.76M418.70%47.48M273.78%18.98M276.57%10.95M1,110.96%10.5M2,237.42%7.06M885.36%9.15M2,042.19%5.08M1,203.59%2.91M
Non-operating interest expense ----------303K------------------0--------
Other net income (expense) 1.92M1.1M115K
Gain on sale of security --1.91M--3.91M--------------------------------
Other non- operating income (expenses) --16K---2.81M--115K----------------------------
Income before tax -35.54%-133.23M-70.35%-116M-76.57%-439.89M-184.64%-161.19M-52.53%-112.3M-60.56%-98.3M-18.13%-68.1M-33.16%-249.13M-7.51%-56.63M-39.07%-73.63M
Income tax 00-739.05%-3.52M378.86%343K-1,202.02%-3.87M00-420K-123K-297K
Net income -35.54%-133.23M-70.35%-116M-75.46%-436.37M-185.87%-161.54M-47.87%-108.43M-60.56%-98.3M-18.13%-68.1M-32.93%-248.71M-7.27%-56.51M-38.51%-73.33M
Net income continuous Operations -35.54%-133.23M-70.35%-116M-75.46%-436.37M-185.87%-161.54M-47.87%-108.43M-60.56%-98.3M-18.13%-68.1M-32.93%-248.71M-7.27%-56.51M-38.51%-73.33M
Minority interest income
Net income attributable to the parent company -35.54%-133.23M-70.35%-116M-75.46%-436.37M-185.87%-161.54M-47.87%-108.43M-60.56%-98.3M-18.13%-68.1M-32.93%-248.71M-7.27%-56.51M-38.51%-73.33M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -35.54%-133.23M-70.35%-116M-75.46%-436.37M-185.87%-161.54M-47.87%-108.43M-60.56%-98.3M-18.13%-68.1M-32.93%-248.71M-7.27%-56.51M-38.51%-73.33M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg